Achieving High-Quality Patient Outcomes in Spinal Muscular Atrophy: A Review of New Data and Managed Care Strategies
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
3
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5
